Resources

Publication: The Multifunctional Role of Poloxamer P338 as a Biofilm Disrupter and Antibiotic Enhancer: A Small Step forward against the Big Trouble of Catheter-Associated Escherichia coli Urinary Tract Infections

De Angelis et al. used a BioFlux Shear Flow System with silicone bottom plates to investigate the use of poloxamer 388 (P338) as an anti-biofilm compound that can be used to manage catheter-associated urinary tract infections. The group found that a 0.5% P338 solution was able to reduce Escherichia coli volume and area up to 50% and disaggregate biofilms up to 34%.

Related Resources

In this study the CERO 3D Incubator & Bioreactor was used for the generation of tumor spheroids from human colon cancer cell line HT29-MTX-E12. The...

The paper discusses the use of induced pluripotent stem cells (iPSCs) in various biomedical applications, specifically for toxicity testing. The authors describe their strategies for...

The paper presents a protocol for the large-scale production of renal proximal tubular epithelial cells (PTEC) derived from human pluripotent stem cells (hPSC). The researchers...